Elbasvir is a small molecule NS5A inhibitor used in research for chronic hepatitis C virus (HCV) infection. It is applied in both in vitro virology studies and in vivo animal models to investigate antiviral mechanisms and combination therapy efficacy, supporting the development of direct-acting antiviral regimens.